Hepatocellular Carcinoma in the Era of COVID-19
The programme is designed to offer an expert opinion exchange and provide some practical approaches for management of Hepatocellular Carcinoma during the COVID-19 pandemic.
Hepatocellular Carcinoma in the Era of COVID-19
Chair: Florian Lordick
Speakers: Florian von Bömmel, Arndt Vogel
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
Programme
- Introduction, Florian Lordick, MD, PhD, University Cancer Centre Leipzig, University Hospital Leipzig, Leipzig, Germany
- Case presentation, Florian von Bömmel, MD, University Hospital Leipzig, Leipzig, Germany
- Management of hepatocellular carcinoma according to the recent ESMO COVID-19 recommendations, Florian Lordick, MD, PhD, University Cancer Centre Leipzig, University Hospital Leipzig, Leipzig, Germany
- Discussion, Florian Lordick, MD, PhD, University Cancer Centre Leipzig, University Hospital Leipzig, Leipzig, Germany, Florian von Bömmel, MD, University Hospital Leipzig, Leipzig, Germany, Arndt Vogel, MD, Hannover Medical School, Hannover, Germany
- Closing Remarks, Florian Lordick, MD, PhD, University Cancer Centre Leipzig, University Hospital Leipzig, Leipzig, Germany
Learning objectives
- Understand the impact of the COVID-19 pandemic in the management of hepatocellular carcinoma patients
- Review the recent ESMO adpted recommendations on hepatocellular carcinoma in the COVID-19 era
- Present a case of patient with hepatocellular carcinoma
- Discuss the case of patient with hepatocellular carcinoma under the guidance of a moderator senior expert, author of the ESMO COVID-19 recommendations assisted with the speakers’ panel
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
